Circulating micro RNAs are promising novel biomarkers of acute myocardial infarction

Internal Medicine

Volumn 50, Issue 17, 2011, Pages 1789-1795

  Wang, Rongrong ^a   Li, Ning ^a   Zhang, Yinhui ^a   Ran, Yuqin ^a   Pu, Jielin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Biomarker; miR 133; miR 328

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB; ENDOTHELIN 1; MICRORNA; MICRORNA 133; MICRORNA 328; TROPONIN I; UNCLASSIFIED DRUG; MIRN133 MICRORNA, HUMAN; MIRN328 MICRORNA, HUMAN;

ACUTE HEART INFARCTION; ADULT; AMINO ACID BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BRADYCARDIA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; TACHYCARDIA; AGED; BLOOD; COMPARATIVE STUDY; HEART INFARCTION; MIDDLE AGED; PHYSIOLOGY; UPREGULATION;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; UP-REGULATION;

EID: 80052418905     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5129     Document Type: Article

References (27)

1. Kloosterman WP, Plasterk RH. The diverse functions of micro- RNAs in animal development and disease. Dev Cell 11: 441-450, 2006.
2. Zhang C. MicroRNAs: role in cardiovascular biology and disease. Clin Sci (Lond) 114: 699-706, 2008.
3. Shan ZX, Lin QX, Fu YH, et al. Upregulated expression of miR- 1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun 381: 597-601, 2009.
4. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618, 2007.
5. Divakaran V, Mann DL. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103: 1072-1083, 2008.
6. Yang B, Lu Y, Wang Z. Control of cardiac excitability by micro- RNAs. Cardiovasc Res 79: 571-580, 2008.
7. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
8. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505, 2010.
9. Tijsen AJ, Creemers EE, Moerland PD, et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res 106: 1035-1039, 2010.
10. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106: 4402-4407, 2009.
11. Meder B, Katus HA, Rottbauer W. Right into the heart of microRNA-133a. Genes Dev 22: 3227-3231, 2008.
12. Bostjancic E, Zidar N, Stajer D, Glavac D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115: 163-169, 2010.
13. Lu Y, Zhang Y, Wang N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122: 2378-2387, 2010.
14. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 28: 2525-2538, 2007.
15. Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-666, 2010.
16. D'Alessandra Y, Devanna P, Limana F, et al. Circulating micro- RNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31: 2765-2773, 2010.
17. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 391: 73-77, 2010.
18. Boissonneault V, Plante I, Rivest S, Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284: 1971-1981, 2009.
19. Wang CH, Lee DY, Deng Z, et al. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One 3: e2420, 2008.
20. Pan YZ, Morris ME, Yu AM. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 75: 1374-1379, 2009.
21. Malzkorn B, Wolter M, Liesenberg F, et al. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20: 539-550, 2010.
22. Dimmeler S, Zeiher AM. Circulating microRNAs: novel biomarkers for cardiovascular diseases? Eur Heart J 31: 2705-2707, 2010.
23. Abbas NA, John RI, Webb MC, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 51: 2059-2066, 2005.
24. Xiao J, Luo X, Lin H, et al. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 282: 12363-12367, 2007.
25. Luo X, Xiao J, Lin H, et al. Transcriptional activation by stimulating protein 1 and post-transcriptional repression by musclespecific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol 212: 358-367, 2007.
26. Luo X, Lin H, Pan Z, et al. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem 283: 20045-20052, 2008.
27. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83: 902-912, 1991.